---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-027969"
form_type: "8-K"
ticker: null
cik: "0001733413"
company_name: "TFF Pharmaceuticals, Inc."
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:15:07.287375+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# TFF Pharmaceuticals amends bylaws to adopt universal proxy rules and other governance changes

## Summary
- Board approved First Amended and Restated Bylaws on March 31, 2023, effective immediately.
- Section 2.14 adopts universal proxy provisions under Rule 14a-19 of the Exchange Act.
- Section 2.12 permits stockholder action by majority written consent unless prohibited by charter.
- Section 3.9 allows removal of directors with or without cause by majority vote of shares.
- Other revisions reflect recent changes in Delaware General Corporation Law; no material impact on prior disclosures.

## SEC filing metadata
- accession: 0001213900-23-027969
- form_type: 8-K
- cik: 0001733413
- company_name: TFF Pharmaceuticals, Inc.
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733413/000121390023027969/0001213900-23-027969-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733413/000121390023027969/ea176605-8k_tffpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-027969
- JSON: https://secwatch.observer/filing/0001213900-23-027969.json
- Plain text: https://secwatch.observer/filing/0001213900-23-027969.txt

## Key facts
- Governance Changes
  TFF Pharmaceuticals, Inc.: Adopted First Amended and Restated Bylaws with universal proxy provisions, majority written consent for stockholder action, and director removal provisions (effective 2023-03-31).
  - Change: bylaw amendment
  - Effective: 2023-03-31
  source text: On March 31, 2023, our Board of Directors approved and adopted our First Amended and Restated Bylaws (“Amended Bylaws”) of the Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733413/000121390023027969/0001213900-23-027969-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.